SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,770,000 | +15.8% | 200,000 | 0.0% | 0.10% | +32.9% |
| Q1 2021 | $4,118,000 | -16.0% | 200,000 | 0.0% | 0.07% | -30.5% |
| Q4 2020 | $4,900,000 | -42.3% | 200,000 | -33.3% | 0.10% | -49.0% |
| Q3 2020 | $8,493,000 | +179.2% | 300,000 | 0.0% | 0.21% | +347.8% |
| Q4 2017 | $3,042,000 | -65.5% | 300,000 | -45.5% | 0.05% | -69.7% |
| Q3 2017 | $8,822,000 | +30.1% | 550,000 | -8.3% | 0.15% | +28.8% |
| Q2 2017 | $6,780,000 | +0.3% | 600,000 | 0.0% | 0.12% | -21.3% |
| Q1 2017 | $6,762,000 | -2.4% | 600,000 | -14.3% | 0.15% | -2.6% |
| Q4 2016 | $6,930,000 | +12.8% | 700,000 | +40.0% | 0.15% | +26.2% |
| Q3 2016 | $6,145,000 | -31.8% | 500,000 | +61.3% | 0.12% | -34.4% |
| Q2 2016 | $9,006,000 | +50.7% | 310,000 | +37.8% | 0.19% | +59.0% |
| Q1 2016 | $5,976,000 | -2.7% | 225,000 | +28.6% | 0.12% | +1.7% |
| Q4 2015 | $6,141,000 | +3.6% | 175,000 | -12.5% | 0.12% | -12.9% |
| Q3 2015 | $5,928,000 | -10.7% | 200,000 | +25.0% | 0.13% | -53.8% |
| Q2 2015 | $6,642,000 | – | 160,057 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |